Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017 Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …
News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017 Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …
News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017 Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …
News
device_magnetic

Magnetic implant could revolutionise drug delivery

February 15, 2017 Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant

Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …
News
614px-flexed_plastic_display

Plastic electronics to bring “mind-blowing” developments for pharma

February 14, 2017 Manufacturing and Production, Research and Development plastic electronics

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …
News
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017 Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …
News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …
Feature
iphone

First-ever approved fertility app more effective than the pill, experts say

February 13, 2017 Research and Development, Sales and Marketing contraception

Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …
News
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …
Appointment
thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …
Appointment
intelligent_fingerprinting

Intelligent Fingerprinting secures £3 million funding for portable drug screening

February 10, 2017 Medical Communications, Research and Development Intelligent Fingerprinting, drug testing, nanotechnology

Intelligent Fingerprinting has received a funding boost to market its fingerprint-based drug screening system further. It is the world’s first …
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Two of our top five stories this month are about one company in particular – a company that’s having a …
News
mother-board-581597_960_720

Three quarters of healthcare companies to invest in big data by 2021

February 9, 2017 Medical Communications, Research and Development Big Data, analytics, clinical trials

The latest research by GBI Research suggests that there may be shift towards the use of big data and analytics …
News
europe-633476_960_720

Top five European countries by pharmaceutical spending per capita

February 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing European Pharmaceutical, pharmaceutical market, price

With pricing never far from the news and yet more news stories emerging around the inflated prices of certain generics …
Feature

Two Phase 3 failures put nail in the coffin for Lundbeck Alzheimer’s drug

February 9, 2017 Research and Development, Sales and Marketing Alzheimer's, Lundbeck, idalopirdine

Danish pharma firm Lundbeck has announced the failure of two Phase 3 trials investigating its experimental Alzheimer’s treatment idalopirdine; the …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026